These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9686884)

  • 1. Sensitive assay for midazolam and its metabolite 1'-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography.
    Eeckhoudt SL; Desager JP; Horsmans Y; De Winne AJ; Verbeeck RK
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):165-71. PubMed ID: 9686884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity.
    Yasui-Furukori N; Inoue Y; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):153-7. PubMed ID: 15522714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A.
    Carrillo JA; Ramos SI; Agundez JA; Martinez C; Benitez J
    Ther Drug Monit; 1998 Jun; 20(3):319-24. PubMed ID: 9631930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children.
    Muchohi SN; Ward SA; Preston L; Newton CR; Edwards G; Kokwaro GO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):1-7. PubMed ID: 15914101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.
    Streetman DS; Kashuba AD; Bertino JS; Kulawy R; Rocci ML; Nafziger AN
    Pharmacogenetics; 2001 Jun; 11(4):349-55. PubMed ID: 11434513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of midazolam and its alpha-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography.
    Ha HR; Rentsch KM; Kneer J; Vonderschmitt DJ
    Ther Drug Monit; 1993 Aug; 15(4):338-43. PubMed ID: 8236371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.
    de Loor H; de Jonge H; Verbeke K; Vanrenterghem Y; Kuypers DR
    Biomed Chromatogr; 2011 Oct; 25(10):1091-8. PubMed ID: 21204116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of midazolam and two of its metabolites in human plasma by high-performance liquid chromatography.
    Mastey V; Panneton AC; Donati F; Varin F
    J Chromatogr B Biomed Appl; 1994 May; 655(2):305-10. PubMed ID: 8081479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid high-performance liquid chromatographic method for the measurement of midazolam plasma concentrations during long-term infusion in ICU patients.
    Van Brandt N; Hantson P; Mahieu P; Verbeeck RK
    Ther Drug Monit; 1997 Jun; 19(3):352-7. PubMed ID: 9200778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement by HPLC of midazolam and its major metabolite, 1-hydroxymidazolam in plasma of very premature neonates.
    Lee TC; Charles B
    Biomed Chromatogr; 1996; 10(2):65-8. PubMed ID: 8924728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography.
    Lehmann B; Boulieu R
    J Chromatogr B Biomed Appl; 1995 Dec; 674(1):138-42. PubMed ID: 8749262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
    Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.
    Moorthy GS; Jogiraju H; Vedar C; Zuppa AF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1067():1-9. PubMed ID: 28978489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients.
    Lee HS; Goh BC; Fan L; Khoo YM; Wang L; Lim R; Ong AB; Chua C
    Br J Clin Pharmacol; 2003 Mar; 55(3):270-7. PubMed ID: 12630977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry.
    Dostalek M; Macwan JS; Chitnis SD; Ionita IA; Akhlaghi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1629-33. PubMed ID: 20434409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography-electrospray mass spectrometry.
    Marquet P; Baudin O; Gaulier JM; Lacassie E; Dupuy JL; François B; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):137-44. PubMed ID: 10574199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.
    Burhenne J; Halama B; Maurer M; Riedel KD; Hohmann N; Mikus G; Haefeli WE
    Anal Bioanal Chem; 2012 Mar; 402(7):2439-50. PubMed ID: 22252655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fast and simple method for the simultaneous analysis of midazolam, 1-hydroxymidazolam, 4-hydroxymidazolam and 1-hydroxymidazolam glucuronide in human serum, plasma and urine.
    Wessels AMA; Bolhuis MS; Bult W; Nijsten MWN; Kneyber MCJ; Touw DJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122476. PubMed ID: 33385770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.